What certifications does the machine have?

The machine is certified with CE, GMP, and ISO.

What is the warranty period?

We provide a 1-year warranty for the machine.

Cfq-1 Pill Polisher Machine for Pharmaceutical Industry

Name: Cfq-1 Pill Polisher Machine for Pharmaceutical Industry
Brand: Shanghai Pharmaceutical Machinery Co., Ltd.
SKU: 766174135

Shanghai, ChinaShanghai Pharmaceutical Machinery Co., Ltd.

US$1,000.00

1 Set

Product profile

Application

Pharmaceutical Industry

Warranty

1 Year

Motor Power

220V 0.2kw

Model NO.

CFQ-1

Weight

25kg

Overall Dimensions

500*500*1000mm

Production

Tablet Polisher

for Use

Industries

Type

Preparation Machinery

Finished Dosage Form

Tablet

Precision

Certification

CE, GMP, ISO

Voltage

220V

Computerized

Customized

Condition

New

After-sales Service

1 Year

Transport Package

Standard Export Wooden Cases.

Specification

CE and GMP

Trademark

SPM

Origin

China

HS Code

8479820090

Production Capacity

550000tablet/H

Key features

High Production Efficiency: Capable of processing 550,000 tablets per hour for maximum output.

Versatile Application: Suitable for pharmaceutical, food, and chemical industries.

Automatic Separation: Integrates automatic tablet and powder separation technology.

Easy Compatibility: Fits all types of tablet presses easily for seamless integration.

Certified Quality: CE, GMP, and ISO certified for safety and compliance.

Flexible Customization: Offers full, minor, and flexible customization options.

Low Noise Operation: Designed for high productivity with low noise levels.

1 Year Warranty: Comprehensive 1-year warranty coverage for peace of mind.

Company profile

Experienced TeamExhibition ExperienceImporters and ExportersLow MOQ

Shanghai Pharmaceutical Machinery Co., Ltd.

Shanghai, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 20 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤5.71h CertifiedTerms of Payment: T/T, LC, PayPal, etc.

AI-Powered supplier vetting

SummaryThe supplier is identified as a Shanghai-based combined trading company with listed pharmaceutical equipment products and machining-related facilities. It reports extensive customization, R&D activity with new products in the past year, export experience of 20 years, and exports representing 90% of total sales. After-sales support includes repair services and overseas agents or branches, but no overseas warehouse or showroom. Finished-product inspection instructions are reportedly available and uniformly followed. The supplier does not provide ODM services, lacks an available SDK, and does not provide OEM services for well-known brands. Evidence is insufficient to verify certifications, detailed financial credibility, production scale, or named customer cases.

After-Sales capabilityThe supplier reports repair as an overseas service offering and states that it can provide services through overseas agents or branches. However, it has no overseas warehouse or showroom, so the evidence supports some service access but not comprehensive overseas infrastructure.

R&D capabilityThe supplier reports R&D capability and states that it launched new products during the past year. It does not have an available SDK and does not provide ODM services, but these limitations do not negate the explicit evidence of recent product development.

Production capacityThe supplier lists machining centers, CNC and milling equipment, provides a broad pharmaceutical-equipment product range, and reports a finished-product inspection method with instructions that are uniformly followed. However, the supplied data does not quantify production capacity, output, or manufacturing ownership, so production strength is only partially evidenced.

Customization capabilityBoth R&D and design-service records explicitly list customization from samples, designs, full customization, minor customization, and flexible customization. This is direct evidence of a broad customization offering.